Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. [electronic resource]
Producer: 20121016Description: 815-8 p. digitalISSN:- 1542-7714
- Anti-Bacterial Agents -- administration & dosage
- Ascites -- drug therapy
- Blood Pressure
- Cardiac Output
- Endotoxins -- blood
- Hemodynamics -- drug effects
- Humans
- Interleukin-6 -- blood
- Kidney -- drug effects
- Kidney Function Tests
- Liver Cirrhosis, Alcoholic -- complications
- Male
- Middle Aged
- Pilot Projects
- Prospective Studies
- Renin -- blood
- Rifamycins -- administration & dosage
- Rifaximin
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.